|
1
|
Morin RD, Mendez-Lago M, Mungall AJ, Goya
R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field
M, et al: Frequent mutation of histone-modifying genes in
non-Hodgkin lymphoma. Nature. 476:298–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fang P, Zhang X, Gao Y, Ding CR, Cui F and
Jiao SC: Reversal effect of melanoma differentiation associated
gene-7/interleukin-24 on multidrug resistance in human
hepatocellular carcinoma cells. Anat Rec. 295:1639–1646. 2012.
View Article : Google Scholar
|
|
3
|
Huo W, Li ZM, Zhu XM, Bao YM and An LJ:
MDA-7/IL-24 suppresses tumor adhesion and invasive potential in
hepatocellular carcinoma cell lines. Oncol Rep. 30:986–992.
2013.PubMed/NCBI
|
|
4
|
Rahmani M, Mayo M, Dash R, Sokhi UK,
Dmitriev IP, Sarkar D, Dent P, Curiel DT, Fisher PB and Grant S:
Melanoma differentiation associated gene-7/interleukin-24 potently
induces apoptosis in human myeloid leukemia cells through a process
regulated by endoplasmic reticulum stress. Mol Pharmacol.
78:1096–1104. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dong CY, Zhang F, Duan YJ, Yang BX, Lin YM
and Ma XT: mda-7/IL-24 inhibits the proliferation of hematopoietic
malignancies in vitro and in vivo. Exp Hematol. 36:938–946. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qian W, Liu J, Tong Y, Yan S, Yang C, Yang
M and Liu X: Enhanced antitumor activity by a selective
conditionally replicating adenovirus combining with
MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of
apoptosis. Leukemia. 22:361–369. 2008. View Article : Google Scholar
|
|
7
|
Sahoo A and Im SH: Molecular mechanisms
governing IL-24 gene expression. Immune Netw. 12:1–7. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gopalan B, Shanker M, Chada S and Ramesh
R: MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro
and in vivo. Mol Cancer. 6:112007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pataer A, Vorburger SA, Barber GN, Chada
S, Mhashilkar AM, Zou-Yang H, Stewart AL, Balachandran S, Roth JA,
Hunt KK, et al: Adenoviral transfer of the melanoma
differentiation-associated gene 7 (mda7) induces apoptosis of lung
cancer cells via up-regulation of the double-stranded RNA-dependent
protein kinase (PKR). Cancer Res. 62:2239–2243. 2002.PubMed/NCBI
|
|
10
|
Yan F, Bai LP, Gao H, Zhu CM, Lin L and
Kang XP: EGF reverses multi-drug resistance via the p-ERK pathway
in HepG2/ADM and SMMC7721/ADM hepatocellular carcinoma models.
Asian Pac J Cancer Prev. 15:2619–2623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang NN, Zhao LJ, Wu LN, He MF, Qu JW,
Zhao YB, Zhao WZ, Li JS and Wang JH: Mechanistic analysis of
taxol-induced multidrug resistance in an ovarian cancer cell line.
Asian Pac J Cancer Prev. 14:4983–4988. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yan F, Wang XM, Pan C and Ma QM:
Down-regulation of extracellular signal-regulated kinase 1/2
activity in P-glycoprotein-mediated multidrug resistant
hepatocellular carcinoma cells. World J Gastroenterol.
15:1443–1451. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suh HN and Han HJ: Collagen I regulates
the self-renewal of mouse embryonic stem cells through α2β1
integrin- and DDR1-dependent Bmi-1. J Cell Physiol. 226:3422–3432.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jayakumar T, Chiu CC, Wang SH, Chou DS,
Huang YK and Sheu JR: Anti-cancer effects of CME-1, a novel
polysaccharide, purified from the mycelia of Cordyceps sinensis
against B16-F10 melanoma cells. J Cancer Res Ther. 10:43–49. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sánchez-Mir L, Soto T, Franco A, Madrid M,
Viana RA, Vicente J, Gacto M, Pérez P and Cansado J: Rho1 GTPase
and PKC ortholog Pck1 are upstream activators of the cell integrity
MAPK pathway in fission yeast. PLoS One. 9:e880202014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen S, Wang Z, Dai X, Pan J, Ge J, Han X,
Wu Z, Zhou X and Zhao T: Re-expression of microRNA-150 induces
EBV-positive Burkitt lymphoma differentiation by modulating c-Myb
in vitro. Cancer Sci. 104:826–834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu Y, Zheng H, Kang JS, Zhang L, Su J, Li
HY and Sun LK: 5-Nitro-2-(3-phenylpropylamino) benzoic acid induced
drug resistance to cisplatin in human erythroleukemia cell lines.
Anat Rec. 294:945–952. 2011. View
Article : Google Scholar
|
|
18
|
Zhu X, Ma Y and Liu D: Novel agents and
regimens for acute myeloid leukemia: 2009 ASH annual meeting
highlights. J Hematol Oncol. 3:172010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Emdad L, Lebedeva IV, Su ZZ, Sarkar D,
Dent P, Curiel DT and Fisher PB: Melanoma differentiation
associated gene-7/interleukin-24 reverses multidrug resistance in
human colorectal cancer cells. Mol Cancer Ther. 6:2985–2994. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Loo TW, Bartlett MC, Shi L and Clarke DM:
Corrector-mediated rescue of misprocessed CFTR mutants can be
reduced by the P-glycoprotein drug pump. Biochem Pharmacol.
83:345–354. 2012. View Article : Google Scholar
|
|
21
|
Wang E, Bhattacharyya S, Szabolcs A,
Rodriguez-Aguayo C, Jennings NB, Lopez-Berestein G, Mukherjee P,
Sood AK and Bhattacharya R: Enhancing chemotherapy response with
Bmi-1 silencing in ovarian cancer. PLoS One. 6:e179182011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Baird NJ, Fang XW, Srividya N, Pan T and
Sosnick TR: Folding of a universal ribozyme: The ribonuclease P
RNA. Q Rev Biophys. 40:113–161. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tokiniwa H, Horiguchi J, Takata D, Kikuchi
M, Rokutanda N, Nagaoka R, Sato A, Odawara H, Tozuka K, Oyama T, et
al: Topoisomerase II alpha expression and the Ki-67 labeling index
correlate with prognostic factors in estrogen receptor-positive and
human epidermal growth factor type-2-negative breast cancer. Breast
Cancer. 19:309–314. 2012. View Article : Google Scholar
|
|
24
|
Lu D, Shi HC, Wang ZX, Gu XW and Zeng YJ:
Multidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and
LRP as prognostic factors in primary ovarian carcinoma. Br J Biomed
Sci. 68:69–74. 2011.PubMed/NCBI
|
|
25
|
Ohsawa M, Ikura Y, Fukushima H, Shirai N,
Sugama Y, Suekane T, Hirayama M, Hino M and Ueda M:
Immunohistochemical expression of multidrug resistance proteins as
a predictor of poor response to chemotherapy and prognosis in
patients with nodal diffuse large B-cell lymphoma. Oncology.
68:422–431. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Crea F, Duhagon Serrat MA, Hurt EM, Thomas
SB, Danesi R and Farrar WL: BMI1 silencing enhances docetaxel
activity and impairs antioxidant response in prostate cancer. Int J
Cancer. 128:1946–1954. 2011. View Article : Google Scholar
|
|
27
|
Siddique HR, Parray A, Tarapore RS, Wang
L, Mukhtar H, Karnes RJ, Deng Y, Konety BR and Saleem M: BMI1
polycomb group protein acts as a master switch for growth and death
of tumor cells: Regulates TCF4-transcriptional factor-induced BCL2
signaling. PLoS One. 8:e606642013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu D, Wan X, Huang H, Chen X, Liang W,
Zhao F, Lin T, Han J and Xie W: Knockdown of Bmi1 inhibits the
stemness properties and tumorigenicity of human bladder cancer stem
cell-like side population cells. Oncol Rep. 31:727–736. 2014.
|
|
29
|
Zhu WY, Hunag YY, Liu XG, He JY, Chen DD,
Zeng F, Zhou JH and Zhang YK: Prognostic evaluation of CapG,
gelsolin, P-gp, GSTP1, and Topo-II proteins in non-small cell lung
cancer. Anat Rec. 295:208–214. 2012. View
Article : Google Scholar
|
|
30
|
Rigoni M, Riganti C, Vitale C, Griggio V,
Campia I, Robino M, Foglietta M, Castella B, Sciancalepore P,
Buondonno I, et al: Simvastatin and downstream inhibitors
circumvent constitutive and stromal cell-induced resistance to
doxorubicin in IGHV unmutated CLL cells. Oncotarget. 6:29833–29846.
2015.PubMed/NCBI
|
